| Stage | DMC | % of rev | SBH | % of rev | Gap · A − B |
|---|---|---|---|---|---|
| Revenue | $1.1B | 100.00% | $935M | 100.00% | DMC ×1.17 |
| Gross profit | $103M | 9.37% | $490M | 52.41% | SBH +43.0pp |
| Operating income | $29M | 2.66% | $86M | 9.24% | SBH +6.6pp |
| Pre-tax income | $26M | 2.36% | $73M | 7.77% | SBH +5.4pp |
| Net income | $19M | 1.71% | $54M | 5.78% | SBH +4.1pp |
| Stage | DMC | SBH | Gap · A − B |
|---|---|---|---|
| Revenue | $1.1B100.00% | $935M100.00% | DMC ×1.17 |
| Gross profit | 9.37%$103M | 52.41%$490M | SBH +43.0pp |
| Operating income | 2.66%$29M | 9.24%$86M | SBH +6.6pp |
| Pre-tax income | 2.36%$26M | 7.77%$73M | SBH +5.4pp |
| Net income |
| 1.71%$19M |
| 5.78%$54M |
| SBH +4.1pp |
No disclosed counterparties: SBH.
None